FDA Approves Merck's DIFICID® (fidaxomicin) to Treat Clostridioides difficile in Children Aged Six Months and Older | Small Molecules | News Channels - PipelineReview.com
FDA Approves Merck's DIFICID® (fidaxomicin) to Treat Clostridioides difficile in Children Aged Six Months and Older | Small Molecules | News Channels PipelineReview.com
Comments
Post a Comment